280 related articles for article (PubMed ID: 16583462)
1. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
2. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
3. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
[TBL] [Abstract][Full Text] [Related]
4. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
Petroianu GA; Arafat K; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
[TBL] [Abstract][Full Text] [Related]
5. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
[TBL] [Abstract][Full Text] [Related]
6. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
Lorke DE; Petroianu GA
J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
[TBL] [Abstract][Full Text] [Related]
7. New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon.
Petroianu GA; Hasan MY; Nurulain SM; Nagelkerke N; Kassa J; Kuca K
Toxicol Mech Methods; 2007; 17(7):401-8. PubMed ID: 20020943
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
[TBL] [Abstract][Full Text] [Related]
9. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
10. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
[TBL] [Abstract][Full Text] [Related]
11. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
12. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
[TBL] [Abstract][Full Text] [Related]
13. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sha Ullah M; Naseer O
J Appl Toxicol; 2005; 25(1):68-73. PubMed ID: 15669039
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
16. In vitro protection of plasma cholinesterases by metoclopramide from inhibition by paraoxon.
Petroianu G; Kühn F; Thyes C; Ewald V; Missler A
J Appl Toxicol; 2003; 23(1):75-9. PubMed ID: 12518340
[TBL] [Abstract][Full Text] [Related]
17. Metoclopramide protection of cholinesterase from paraoxon inhibition.
Petroianu GA; Hasan MY; Kosanovic M; Vijayasarathy C; Saleh AM
Vet Hum Toxicol; 2003 Oct; 45(5):251-3. PubMed ID: 14513894
[TBL] [Abstract][Full Text] [Related]
18. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime.
Lorke DE; Hasan MY; Nurulain SM; Sheen R; Kuca K; Petroianu GA
J Appl Toxicol; 2007; 27(5):482-90. PubMed ID: 17309042
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods.
Kassa J; Cabal J
Hum Exp Toxicol; 1999 Sep; 18(9):560-5. PubMed ID: 10523870
[TBL] [Abstract][Full Text] [Related]
20. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
